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the "better patient selection" excuse for defining the 
future role of skeletal muscle assistance. 
Norman A. Silverman, MD 
Division Head 
Cardiac and Thoracic Surgery 
Henry Ford Hospital 
2799 West Grand Blvd. 
Detroit, MI 48202 
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Aortopulmonary paraganglioma, a rare tumor 
To the Editor: 
I read with interest the letter on aortopulmonary para- 
ganglioma by Castafion and associates, 1 who referred also 
to our case of intrathoracic chemodectoma (or paragan- 
glioma) with multiple localizations, z I would like to recall 
the Carney triad of extraadrenal paraganglioma, pulmo- 
nary chondroma, and gastrointestinal leiomyo(sarco)ma. 
After reviewing the clinical data and the available histo- 
logic data on our case, Carney included our case in a series 
of patients with the triad from the Mayo Clinic and from 
the literature) 
Our case concerned a female patient who underwent 
at the age of 31 years a resection of an anterosuperior 
mediastinal chemodectoma. An esophageal nomaly had 
been discovered at the age of 16 years, during an episode 
of vomiting, but because the patient was afterward asymp- 
tomatic, she refused any further investigation of the 
esophagus. Seventeen years later the patient had a second 
operation. An aortopulmonary chemodectoma was re- 
sected and a pulmonary osteochondroma of the lingula 
was enucleated. The esophagus was not explored accord- 
ing to the wish of the patient. Two years later, a small 
tumor in the left upper lung lobe was visible and was 
considered to be a new or recurrent benign pulmonary 
hamartochondroma, butagain 2 years later an inoperable 
squamous cell carcinoma of the left main bronchus was 
discovered and the patient died 3 months later at the age 
of 52 years. Postmortem examination was refused by the 
relatives, so that the histologic type of the esophageal 
tumor is still unknown. We believed that the long-lasting 
esophageal nomaly was a benign leiomyoma nd consid- 
ered that our patient had the Carney triad. 
With regard to the case of aortopulmonary paragangli- 
oma reported by Castafion's group, aI have some recom- 
mendations and some comments. 
I recommend regular follow-up of the patient, exclusion 
Of other localizations of the paraganglioma, and exclusion 
of the triad of Carney. There is no chronologic sequence 
in the appearance of these three tumors, and their occur- 
rence is more than coincidence) Moreover, malignancy of 
each part of the triad is possible, z'3 
The risk of lung cancer is increased in patients with 
chondromatous hamartoma, whether the hamartoma it- 
self or the fibrous scar or whether both tumors have 
common risk factors. 4 The spatial association was present 
in our case, and the question arises whether the enucle- 
ation of a hamartoma should not be altered in a segmental 
resection. In our case a new small tumor appeared 2 years 
after the enucleation and was, without proof, considered 
to be benign, but another 2 years later lung cancer was 
discovered in the same area. 
Finally, patients with pulmonary hamartoma have a 
high incidence of associated anomalies and benign tumors 
but also an increased susceptibility to development of 
malignant tumors. Therefore, the clinical significance of 
pulmonary hamartoma is in the workup and lifelong 
follow-up of those patients. 5 
Leon 1<2 Lacquet, MD 
Professor and Chairman 
Thoracic and Cardiac Surgery 
University Hospital St. Radboud PB 9101 
6500 HB Nijmegen, The Netherlands 
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Anomalous origin of the left coronary artery from 
the pulmonary artery: New technique or 
modification of "old" technique 
To the Editor." 
We read with interest he article by Tashiro and asso- 
ciates, 1 "Anomalous Origin of the Left Coronary Artery 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 109, Number 2 
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Fig. 1. 
From the Pulmonary Artery: New Operative Technique." 
Use of native pulmonary artery to fashion a tube that 
would then allow connection of the left coronary artery to 
the aorta is an excellent option when direct implantation 
is not possible. 
We discovered a photograph in one of our slide collec- 
tions (J.A.W.) that depicted an operation proposed by Dr. 
Harris Shumacker at Indiana University in 1962, more 
than 30 years ago (Fig. 1). Although the infant died before 
the operation could be undertaken, it was performed in 
the autopsy room. 2 We believe this "old" technique 
should be in the congenital heart surgeons' armentarimn 
when faced with a patient in whom the left coronary artery 
cannot be directly reimplanted and some other technique 
is required to span the distance from the aorta to the 
ostium of the left coronary artery. 
John L. ?dyers, MD 
John A. Waldhausen, MD 
The Pennsylvania State University 
The Milton S. Hershey Medical Center 
Hershey, PA 17033 
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Topical effect of aprotinin on the surgical wound 
in cardiac surgery 
To the Editor: 
The best way to apply aprotinin is unknown in cardiac 
surgery, because the mechanism of aprotinin in preserving 
hemostasis remains under investigation, a' 2 We have been 
recommending the use of low-dose aprotinin (2 million 
KIU) in the pump prime, because we demonstrated that 
low-dose aprotinin is sufficient o preserve platelet glyco- 
protein Ib receptors 3 and ristocetin agglutination capacity 
of platelets 4 during cardiopulmonary b pass (CPB). These 
seem to be the main mechanisms of aprotinin in preserv- 
ing hemostasis. This efficacy and the sufficiency of low- 
dose aprotinin were reproduced by the ptatelet aggrega- 
tion model on the extracellular matrix. 5Another possible 
mechanism of aprotinin in preserving hemostasis i the 
preservation of fibrin hemostatic sealing by the inhibition 
of fibrinolysis, a However, the direct effect of fibrinolysis in 
impairing hemostasis remains unclear, 1because no clear 
evidence has been collected regarding how much the 
increase of fibrin-split products in the systemic irculation 
stands for the lysis of fibrin hemostatic sealing on the 
wound surface. 
Of great interest is a recent report of Tatar and 
associates, ~ who demonstrated the efficacy of aprotinin 
(1 million KIU) on hemostasis when used topically in the 
pericardial cavity before closure of the thorax cavity. This 
observation certainly suggests that the inhibition of fibri- 
nolysis on the closed thorax cavity stabilizes the fibrin 
hemostatic sealing on the wound surface, contributing to 
hemostasis. If aprotinin is applied topically, its effect 
seems olely based on antifibrinolysis. In a previous tudy, 
we 7 demonstrated enormous activation of fibrinolysis on 
the surgical wound by sampling blood from the thoracic 
cavity. This method might reveal the topical effect of 
